Last reviewed · How we verify

NCT05930067

Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical Trials

Completed NA Last updated 10 December 2025
What this trial tests

NA trial testing Pinnacle Gription Acetabular Cup in Hip Osteoarthritis in 82 participants. Completed in 30 May 2025.

Timeline
2 May 2023
Primary endpoint
12 March 2025
30 May 2025

Quick facts

Lead sponsorCanadian Radiostereometric Analysis Network
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment82
Start date2 May 2023
Primary completion12 March 2025
Estimated completion30 May 2025
Sites2 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Canadian Radiostereometric Analysis Network

Who can join

21 and older, any sex, with Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study is a continuation of two prospective, multi-centre, non-controlled studies of the Pinnacle and Pinnacle Dual Mobility total hip arthroplasty systems, originally initiated by DePuy Synthes (DSJ\_2018\_02 and DJS\_2019\_02, respectively).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Other Canadian Radiostereometric Analysis Network trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05930067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing